{"name":"Eurand","permalink":"eurand","crunchbase_url":"http://www.crunchbase.com/company/eurand","homepage_url":"http://www.eurand.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"+31-20-6732744","description":"","created_at":"Sat Dec 04 06:13:51 UTC 2010","updated_at":"Thu Aug 18 23:14:57 UTC 2011","overview":"<p>Eurand N.V. (Eurand) is a holding company. The Company is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. The Company is commercializing a portfolio of products for cystic fibrosis (CF) and gastrointestinal (GI) patients in the United States. As of December 31, 2009, it had two late-stage product candidates, EUR-1073 (beclomethasone) and EUR-1025 (ondansetron) in development in its own portfolio, as well as a number of other products in development with collaboration partners, including EUR-1000, which is partnered with GlaxoSmithKline (GSK). It has manufacturing and research facilities in the United States, Italy and France. </p>","image":{"available_sizes":[[[150,70],"assets/images/resized/0011/2831/112831v1-max-150x150.png"],[[184,87],"assets/images/resized/0011/2831/112831v1-max-250x250.png"],[[184,87],"assets/images/resized/0011/2831/112831v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Chairman of the Board, CEO","person":{"first_name":"Gearoid","last_name":"M. Faherty","permalink":"gearoid-m-faherty","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":{"price_amount":583000000,"price_currency_code":"USD","term_code":"cash","source_url":"http://www.thepressreleasewire.com/client/axcan/n/release.jsp?actionFor=1361779&releaseSeq=0&year=2010","source_description":"Eurand to be Acquired by Axcan for $12.00 per Share in Cash","acquired_year":2010,"acquired_month":12,"acquired_day":1,"acquiring_company":{"name":"Aptalis Pharma","permalink":"aptalis","image":{"available_sizes":[[[150,59],"assets/images/resized/0011/2830/112830v2-max-150x150.png"],[[250,99],"assets/images/resized/0011/2830/112830v2-max-250x250.png"],[[278,111],"assets/images/resized/0011/2830/112830v2-max-450x450.png"]],"attribution":null}}},"acquisitions":[],"offices":[{"description":"","address1":"Olympic Plaza Fred","address2":"Roeskestraat 123","zip_code":"1076 EE","city":"Amsterdam","state_code":null,"country_code":"NLD","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}